Nectar Lifesciences
BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
0.13Net Income/employee - trailing 12 month
50,842.04Revenue/employee - most recent fiscal year
93,53,401.00Return on investment - most recent fiscal year
-1.80Return on average assets - most recent fiscal year
-1.06Receivables turnover - most recent fiscal year
4.19Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.81Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
1,02,71,550.00Return on average assets - 5 year average
0.06Net Income/employee - most recent fiscal year
-1,48,453.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.67Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
-2.25Return on investment - 5 year average
0.10